Shexiang Baoxin pill in patients with stable coronary artery disease and reduced eGFR: Subgroup analysis of phase IV randomized trial
Fields of Study & Subjects
Traditional Chinese Medicine Analysis
Chronic Kidney Disease and Diabetes
Coronary Interventions and Diagnostics
Publication details
- Journal / source
- Phytomedicine
- Publisher
- Elsevier BV
- Volume
- 154
- Pages
- 157946–157946
- Publication date
- 10 February 2026
- Language
- EN